Get the app!
Back to Trades
Grant4

Evommune, Inc.

EVMN

Total Value
$10.0M
Grants
$10.0M
1 transaction

Company Information

Company Name
Evommune, Inc.
Ticker Symbol
EVMN
CIK
0002044725

Insider Information

Role
Insider
Location
PALO ALTO, CA

Filing Details

Filing Date
Feb 18, 2026
Transaction Date
Feb 17, 2026
Accession Number
0002094941-26-000002
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 17, 2026Common Stock358,680$27.88Grant/Award$10.0M

Footnotes

  1. (F1)These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.